Past Events - Research to Practice

May 17

American Urological Association Annual Meeting

Second Opinion: Optimal Management of Localized Renal Cell Carcinoma

ExploreSecond Opinion: Optimal Management of Localized Renal Cell Carcinoma
May 17

American Urological Association Annual Meeting

Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

ExploreSecond Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer
May 16

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Pancreatic Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Pancreatic Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer
May 15

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Immunotherapeutic Approaches for Endometrial Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Immunotherapeutic Approaches for Endometrial Cancer
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Prostate Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Prostate Cancer
May 14

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
May 13

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates
May 13

Annual ONS Congress

Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Ovarian Cancer

ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Ovarian Cancer
May 6

Year in Review

Localized HR-Positive Breast Cancer

ExploreLocalized HR-Positive Breast Cancer
May 5

Year in Review

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer

ExploreNon-Muscle-Invasive and Muscle-Invasive Bladder Cancer
Apr 30

What Clinicians Want to Know

Optimizing the Management of Metastatic Triple-Negative Breast Cancer

ExploreOptimizing the Management of Metastatic Triple-Negative Breast Cancer